Results 61 to 70 of about 4,267 (203)

Plasma Proteomic Profiling of Young and Older Adults Identifies Candidate Biomarkers of Biological Aging at the Intersection of Age and Disease

Aging Cell, Volume 25, Issue 4, April 2026.
By comparing plasma proteomes of young and older adults, as well as older adults with varying levels of disease burden, this study aims to identify plasma proteins at the intersection of age and disease. The identified signature points to potential candidate biomarkers of biological aging.
Juliette Tavenier, Nikolaj Normann Holm, Thomas Kallemose, Morten Baltzer Houlind, Aino Leegaard Andersen, Line Fleischer Hach, Magnus Berglind, Ove Andersen, Jan O. Nehlin, Line Jee Hartmann Rasmussen   +9 more
wiley   +1 more source

Table_2_Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation.xlsx

, 2021
Systemic chronic inflammation (SCI) is persistent, health-damaging, low-grade inflammation that plays a major role in immunosenescence and in development and progression of many diseases.
Jesper Eugen-Olsen (39433), Jens Emil Vang Petersen (11780408), Line Jee Hartmann Rasmussen (8965727)   +2 more
core   +1 more source

Karya patung Supar Madiyanto [PDF]

, 2005
Supar Mardiyanto adalah salah satu seniman patung yang konsens dengan tema - tema kota dan permasalahanya. Tujuan dari penelitian ini sebagai berikut : untuk mengetahui lebih sdekat dan mendalam mengenai seni patung karya Supar Mardiyanto serta untuk ...
KURNIAWAN R., Ilham
core  

Hepatic suPAR formation.

, 2019
Hepatic suPAR formation.
Jan Nehlin (214365), Søren Møller (502423), Christian Mortensen (7325975), Ove Andersen (295030), Lise Hobolth (7325978), Emilie Garnæs (7325972)   +5 more
core   +1 more source

Melatonin and the Dental Pulp: A Scoping Review

International Endodontic Journal, Volume 59, Issue 4, Page 590-613, April 2026.
ABSTRACT Background In general medicine, melatonin is known to enhance wound healing and promote stem cell differentiation. Its potential relevance in endodontics, however, remains underexplored. Objectives This scoping review aimed to systematically assess the available evidence on the effects of melatonin (a) on dental pulp tissue and (b) on human ...
Jasmin Schäfer, Konrad Kleszczynski, Edgar Schäfer   +2 more
wiley   +1 more source

Role of soluble urokinase plasminogen activator receptor in critically ill children with hospital-acquired pneumonia: an observational study in hospital with controls

BMJ Paediatrics Open
Background Diagnosing hospital-acquired pneumonia (HAP) (ventilator-associated pneumonia (VAP) and non-ventilator associated pneumonia (Non-VAP)) is still a hot issue.
Nagwan Yossery Saleh, Shimaa Elshafy Soliman, Mohammed Adel Aboukoura, Mohamed Ibrahim Garib   +3 more
doaj   +1 more source

Companion Diagnostics in Clinical Therapy: Current Applications and Future Directions

MedComm, Volume 7, Issue 3, March 2026.
Companion diagnostics use biomarker‐based assays to stratify patients for precision therapies, improving outcomes while reducing ineffective treatment and side effects. This review summarizes the evolution, regulatory landscape, clinical applications, and technological platforms of CDx, highlighting their role in biomarker‐driven precision therapy.
Yuesong Wu, Rou Xue, Xiangwen Luo, Jiangnan Liao, Zongbo Zhang, Jinhai Deng, Teng Liu, Xin Li, Zhe‐Sheng Chen, Mingzhu Yin   +9 more
wiley   +1 more source

Availability of suPAR in emergency departments may improve risk stratification: a secondary analysis of the TRIAGE III trial

Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, 2019
Introduction Soluble urokinase plasminogen activator receptor (suPAR) is a prognostic and nonspecific biomarker associated with short-term mortality in emergency department (ED) patients.
Martin Schultz, Line J. H. Rasmussen, Thomas Kallemose, Erik Kjøller, Morten N. Lind, Lisbet Ravn, Theis Lange, Lars Køber, Lars S. Rasmussen, Jesper Eugen-Olsen, Kasper Iversen   +10 more
doaj   +1 more source

Measurement of serum suPAR is not ready for clinical use [PDF]

Nature Reviews Nephrology, 2014
Item does not contain ...
Deegens, J.K., Wetzels, J.
openaire   +3 more sources

Mettl3‐Mediated m6A Modification Represents a Novel Therapeutic Target for FSGS

Advanced Science, Volume 13, Issue 10, 18 February 2026.
This study explores the roles of Mettl3‐induced N6‐methyladenosine (m6A) modifications in Focal segmental glomerulosclerosis (FSGS). The findings reveal that inhibition of Mettl3 results in podocyte injury by modulating the TJP1CDC42 pathway. Moreover, Administration of N6‐methyladenosine attenuates the FSGS phenotype in WT mice induced by Adriamycin ...
Fubin Zhu, Hongzhi Li, Xiang Li, Chunxiu Du, Ting Wang, Xuling Zhou, Xiaobei Xie, Yunxia Shao, Yingzhi Huang, Yanling Hu, Xinxin Guo, Bin Zhu, Shanshan Yu, Xiaoyan Zhang, Binghai Zhao   +14 more
wiley   +1 more source